Search for: "ABBOTT v. WYETH" Results 41 - 60 of 111
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Apr 2011, 4:55 am by Marie Louise
(IP Watch) China: Pfizer starts R&D in China after IPR in China challenges (IP Dragon) UK: IPO inviting comment on C-630/10 University of Queensland, CSL Ltd v Comptroller-General of Patents, Designs and Trade Marks and C-130/11 Neurim v Comptroller General of Patents (The SPC Blog) (The SPC Blog) US: New generics quickly grab 80% of sales volume (GenericsWeb) Products Actos (Pioglitazone) – US: Takeda agrees to dismiss one Actos infringement suit against Apotex (Patent… [read post]
15 Feb 2011, 5:26 pm by Marie Louise
: Novozymes v Danisco (Holman’s Biotech IP Blog) US: Preliminary injunction softened after claims are rejected in reexamination: Celsis In Vitor v CellzDirect (Reexamination Alert) Products Alpharen – EU: General Court: Boards of appeal are judges not doctors! [read post]
10 Feb 2011, 9:59 pm by Patent Docs
According to the complaint, Wyeth claimed that Abbott's Xience V stent infringed U.S. [read post]
8 Feb 2011, 10:51 pm by Marie Louise
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey:… [read post]
6 Oct 2010, 4:22 am by Kelly
General Update on the Indo-E.U. trade dispute before the WTO (Spicy IP) Australia: Proceedings in other jurisdictions no excuse for delay: Wyeth v The Kennedy Institute of Rheumatology (Patentology) EU: Positive opinions on Paediatric Investigation Plans (The SPC Blog) EU: Guidelines for biosimilar antibodies in Europe due in November (Patent Docs) Netherlands: Court of Appeal of The Hague dismisses request to suspend execution of judgment in first instance: Sandoz v Leo… [read post]
15 Sep 2010, 2:40 am by Kelly
KG v Apotex Pty Ltd (No 2) (Patentology) MoviPrep – US: Salix and Norgine settle with Novel in patent dispute over MoviPrep (Patent Docs) Nexavar (Sorafenib) – India: Nexavar patent infringement suit before Delhi HC goes directly to trial: Bayer v Cipla (Spicy IP) Simcor (Niacin/Simvastatin) – US: Abbott files patent infringement suit against Teva following Para IV challenge (Patent Docs) Vancocin (Vancomycin) – US: ViroPharma sues FDA over generic… [read post]
7 Sep 2010, 6:10 pm by Kelly
Perrigo Co (IPBiz) Norvir (Ritonavir) – US: Abbott’s HIV/AIDS drug patents challenged by PUBPAT (IP Watchdog) ReFacto (Moroctocog) and Xyntha (Antihemophilic factor) – US: Novartis drops one of three patents from ReFacto/Xyntha suit against Wyeth (Patent Docs) Strattera (Atomoxetine) – US: CAFC grants injunction pending disposition of Lilly v Actavis Elizabeth (Patent Docs) Valcyte (Valganciclovir) – US: Ranbaxy settles patent dispute with… [read post]
2 Sep 2010, 8:35 am by Stefanie Levine
Cal., Case No. 5:06-cv-00244-RMW, filed Jan. 13, 2006) and Rambus Inc. v. [read post]
7 Jul 2010, 5:14 am
(Patent Docs) (Holman's Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs)   Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market… [read post]
6 Jul 2010, 6:03 pm by Duncan
(Patent Docs) (Holman’s Biotech IP Blog) US: AMP v USPTO after Bilski v Kappos (Patent Docs) US: NORD Chair/HP&M Director presents opening testimony at first ever FDA orphan drug hearing (FDA Law Blog) US: Celsis files patent infringement complaint against CellzDirect and Invitrogen over pooled multi-cryopreserved hepatocyte products (Patent Docs)   Products Astelin (Azelastine) – US: Zydus admits infringing Meda’s Astelin patent, agrees not to market… [read post]